N-(2H-1,3-benzodioxol-5-yl)-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
Chemical Structure Depiction of
N-(2H-1,3-benzodioxol-5-yl)-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
N-(2H-1,3-benzodioxol-5-yl)-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
Compound characteristics
| Compound ID: | L707-1316 |
| Compound Name: | N-(2H-1,3-benzodioxol-5-yl)-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide |
| Molecular Weight: | 487.53 |
| Molecular Formula: | C23 H25 N3 O7 S |
| Smiles: | C1CC(N(CC(Nc2ccc3c(c2)OCO3)=O)c2ccc(cc2C1)S(N1CCOCC1)(=O)=O)=O |
| Stereo: | ACHIRAL |
| logP: | 2.5047 |
| logD: | 2.5046 |
| logSw: | -3.0789 |
| Hydrogen bond acceptors count: | 12 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 95.834 |
| InChI Key: | OKTVGWZLFXDYDL-UHFFFAOYSA-N |